ArticleThe Permanente journal2019

Utility of Human Epidermal Growth Factor Receptor 2 (HER2) Retesting of Histologic Grade 3 Invasive Breast Carcinomas.

Rebecca Gologorsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.